Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
<p>Consort diagram of the study.Control arm indicates FOLFOXIRI plus bevacizumab. Atezo arm indicates FOLFOXIRI plus bevacizumab and atezolizumab.</p>
Kaydedildi:
| Yazar: | |
|---|---|
| Diğer Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , |
| Baskı/Yayın Bilgisi: |
2025
|
| Konular: | |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
| _version_ | 1849927633357242368 |
|---|---|
| author | Carlotta Antoniotti (15352506) |
| author2 | Alessandra Boccaccino (15352509) Robert Seitz (15352512) Mirella Giordano (15352515) Aurélie Catteau (15352518) Daniele Rossini (15086287) Filippo Pietrantonio (15035729) Lisa Salvatore (15352521) Kimberly McGregor (15352524) Francesca Bergamo (15352527) Veronica Conca (15352530) Simone Leonetti (15352533) Federica Morano (14937009) Giorgio Papiani (15352536) Emiliano Tamburini (15352539) Maria Bensi (15352542) Sabina Murgioni (15352545) Douglas Teller Ross (15352548) Alessandro Passardi (15352551) Isabelle Boquet (15352554) Tyler J. Nielsen (15352557) Jérôme Galon (15031113) Matthew Gordon Varga (15352560) Brock L. Schweitzer (15352563) Chiara Cremolini (15352566) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Carlotta Antoniotti (15352506) Alessandra Boccaccino (15352509) Robert Seitz (15352512) Mirella Giordano (15352515) Aurélie Catteau (15352518) Daniele Rossini (15086287) Filippo Pietrantonio (15035729) Lisa Salvatore (15352521) Kimberly McGregor (15352524) Francesca Bergamo (15352527) Veronica Conca (15352530) Simone Leonetti (15352533) Federica Morano (14937009) Giorgio Papiani (15352536) Emiliano Tamburini (15352539) Maria Bensi (15352542) Sabina Murgioni (15352545) Douglas Teller Ross (15352548) Alessandro Passardi (15352551) Isabelle Boquet (15352554) Tyler J. Nielsen (15352557) Jérôme Galon (15031113) Matthew Gordon Varga (15352560) Brock L. Schweitzer (15352563) Chiara Cremolini (15352566) |
| author_role | author |
| dc.creator.none.fl_str_mv | Carlotta Antoniotti (15352506) Alessandra Boccaccino (15352509) Robert Seitz (15352512) Mirella Giordano (15352515) Aurélie Catteau (15352518) Daniele Rossini (15086287) Filippo Pietrantonio (15035729) Lisa Salvatore (15352521) Kimberly McGregor (15352524) Francesca Bergamo (15352527) Veronica Conca (15352530) Simone Leonetti (15352533) Federica Morano (14937009) Giorgio Papiani (15352536) Emiliano Tamburini (15352539) Maria Bensi (15352542) Sabina Murgioni (15352545) Douglas Teller Ross (15352548) Alessandro Passardi (15352551) Isabelle Boquet (15352554) Tyler J. Nielsen (15352557) Jérôme Galon (15031113) Matthew Gordon Varga (15352560) Brock L. Schweitzer (15352563) Chiara Cremolini (15352566) |
| dc.date.none.fl_str_mv | 2025-11-25T13:04:58Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707231 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplementary_Figure_S1_from_An_Immune-Related_Gene_Expression_Signature_Predicts_Benefit_from_Adding_Atezolizumab_to_FOLFOXIRI_plus_Bevacizumab_in_Metastatic_Colorectal_Cancer/30707231 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Tumor Biology Cancer Detection and Diagnosis Therapeutic Research and Development Immuno-oncology Biomarkers Gastrointestinal Cancers Colorectal cancer Immunotherapy Biomarkers for immunotherapy Translational Research Tumor Microenvironment Immune cells and the microenvironment |
| dc.title.none.fl_str_mv | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Consort diagram of the study.Control arm indicates FOLFOXIRI plus bevacizumab. Atezo arm indicates FOLFOXIRI plus bevacizumab and atezolizumab.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_f782d85183d40bc2b0f5fd7704efc3ee |
| identifier_str_mv | 10.1158/1078-0432.30707231 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707231 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal CancerCarlotta Antoniotti (15352506)Alessandra Boccaccino (15352509)Robert Seitz (15352512)Mirella Giordano (15352515)Aurélie Catteau (15352518)Daniele Rossini (15086287)Filippo Pietrantonio (15035729)Lisa Salvatore (15352521)Kimberly McGregor (15352524)Francesca Bergamo (15352527)Veronica Conca (15352530)Simone Leonetti (15352533)Federica Morano (14937009)Giorgio Papiani (15352536)Emiliano Tamburini (15352539)Maria Bensi (15352542)Sabina Murgioni (15352545)Douglas Teller Ross (15352548)Alessandro Passardi (15352551)Isabelle Boquet (15352554)Tyler J. Nielsen (15352557)Jérôme Galon (15031113)Matthew Gordon Varga (15352560)Brock L. Schweitzer (15352563)Chiara Cremolini (15352566)CancerTumor BiologyCancer Detection and DiagnosisTherapeutic Research and DevelopmentImmuno-oncologyBiomarkersGastrointestinal CancersColorectal cancerImmunotherapyBiomarkers for immunotherapyTranslational ResearchTumor MicroenvironmentImmune cells and the microenvironment<p>Consort diagram of the study.Control arm indicates FOLFOXIRI plus bevacizumab. Atezo arm indicates FOLFOXIRI plus bevacizumab and atezolizumab.</p>2025-11-25T13:04:58ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30707231https://figshare.com/articles/figure/Supplementary_Figure_S1_from_An_Immune-Related_Gene_Expression_Signature_Predicts_Benefit_from_Adding_Atezolizumab_to_FOLFOXIRI_plus_Bevacizumab_in_Metastatic_Colorectal_Cancer/30707231CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307072312025-11-25T13:04:58Z |
| spellingShingle | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer Carlotta Antoniotti (15352506) Cancer Tumor Biology Cancer Detection and Diagnosis Therapeutic Research and Development Immuno-oncology Biomarkers Gastrointestinal Cancers Colorectal cancer Immunotherapy Biomarkers for immunotherapy Translational Research Tumor Microenvironment Immune cells and the microenvironment |
| status_str | publishedVersion |
| title | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer |
| title_full | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer |
| title_fullStr | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer |
| title_full_unstemmed | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer |
| title_short | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer |
| title_sort | Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer |
| topic | Cancer Tumor Biology Cancer Detection and Diagnosis Therapeutic Research and Development Immuno-oncology Biomarkers Gastrointestinal Cancers Colorectal cancer Immunotherapy Biomarkers for immunotherapy Translational Research Tumor Microenvironment Immune cells and the microenvironment |